Understanding how cells turn genes on and off is one of biology's most enduring mysteries. Now, a new technology developed by ...

Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of ...

Artificial intelligence, according to the report, is emerging as a transformative enabler in Indian agriculture. The Telangana pilot is cited as a key example of how AI-driven precision advisory ...

Cathy Tie, who launched her first biotech in SF's IndieBio, now leads Manhattan Genomics in controversial push to edit human ...

We are now in the second great wave of the genetic revolution, not defined by reading the human code of life, but by rewriting it.

In a separate 2024 study, researchers also made mice temporarily transparent. The study, published in Science, showed that ...

Vertex Pharmaceuticals Incorporated remains a leader in CF treatments, fueling robust cash flow and pipeline expansions.

First clinical data disclosure for CB-011 highlights its potential as a best-in-class allogeneic CAR-T cell therapy for relapsed or refractory multiple myeloma 450 million cell dose is the recommended ...

Data demonstrate efficacy and durability of vispa-cel, an allogeneic anti-CD19 CAR-T cell therapy, are on par with autologous CAR-T cell ...

First clinical data disclosure for CB-011 highlights its potential as a best-in-class allogeneic CAR-T cell therapy for relapsed or refractory ...

The project's database shows that the National Institutes of Health ... mRNA is also being used in tandem with the ...